SB 471-1_ Filed 02/27/2001, 10:05
Adopted 2/27/2001



    The Senate Committee on Health and Provider Services, to which was referred Senate Bill No. 471, has had the same under consideration and begs leave to report the same back to the Senate with the recommendation that said bill be AMENDED as follows:

SOURCE: Page 1, line 1; (01)AM047103.1. -->     Page 1, delete lines 1 through 17, begin a new paragraph and insert:
SOURCE: IC 25-23-1-19.5; (01)AM047103.1. -->     "SECTION 1. IC 25-23-1-19.5 , AS AMENDED BY P.L.83-2000, SECTION 1, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE JULY 1, 2001]: Sec. 19.5. (a) The board shall establish a program under which advanced practice nurses who meet the requirements established by the board are authorized to prescribe legend drugs. including controlled substances (as defined in IC 35-48-1).
    (b) The authority granted by the board under this section:
        (1) expires on October 31 of the odd-numbered year following the year the authority was granted or renewed; and
        (2) is subject to renewal indefinitely for successive periods of two (2) years.
    (c) The rules adopted under section 7 of this chapter concerning the authority of advanced practice nurses to prescribe legend drugs must do the following:
        (1) Require an advanced practice nurse or a prospective advanced practice nurse who seeks the authority to submit an application to the board.
        (2) Require, as a prerequisite to the initial granting of the authority, the successful completion by the applicant of a graduate level course in pharmacology providing at least two (2) semester

hours of academic credit.
        (3) Require, as a condition of the renewal of the authority, the completion by the advanced practice nurse of the continuing education requirements set out in section 19.7 of this chapter.
     (d) A program established under subsection (a) may not allow an advanced practice nurse to prescribe controlled substances (as defined in IC 35-48-1 ).

SOURCE: ; (01)AM047103.2. -->     SECTION 2. [EFFECTIVE JULY 1, 2001] (a) As used in this SECTION, "advisory committee" refers to the controlled substances advisory committee established by IC 35-48-2-1 (f).
    (b) The advisory committee shall review the records maintained by the central repository for controlled substances designated by the state police department under IC 35-48-7-10 regarding the prescribing of psychotropic medications to children.
    (c) Not later than December 1, 2001, the advisory committee shall submit a report to the legislative council, the governor, and the medical licensing board established under IC 25-22.5-2-1 regarding the review required under this SECTION.
    (d) The report required under subsection (c) must include the following:
        (1) A comparison of the number of prescriptions written for psychotropic medications for children:
            (A) participating in Medicaid (IC 12-15) or the children's heath insurance program (IC 12-17.6); and
            (B) not participating in a program described in clause (A).
        (2) A statement by the advisory committee regarding whether the information provided under subdivision (1) indicates that psychotropic medications are being disproportionately prescribed for children described in subdivision (1)(A).
        (3) Identification of any pattern of prescribing of psychotropic medications for children contrary to the most recent guidelines adopted by the American Academy of Pediatrics and the American Academy of Child and Adolescent Psychiatry.
    (e) The report required under subsection (c) may not contain any information that:
        (1) may be used to identify a child for whom a psychotropic medication was prescribed; or
        (2) indicates that a particular physician's prescribing of psychotropic medications to a child was inappropriate.
    (f) Any meeting held by the advisory committee to comply with this SECTION is not open to the public.
    (g) Unless otherwise provided by law, records reviewed by the advisory committee to comply with this SECTION are not public records.
    (h) This SECTION expires December 31, 2001.
    Delete page 2.
    (Reference is to SB 471 as introduced.)

and when so amended that said bill do pass .

Committee Vote: Yeas 9, Nays 0.


Senator Miller, Chairperson

AM 047103/DI 104    2001